Therapeutic option of plasmid-DNA based gene transfer

Current Topics in Medicinal Chemistry

Volumn 12, Issue 15, 2012, Pages 1630-1637

  Taniyama, Yoshiaki ^a   Azuma, Junya ^a   Kunugiza, Yasuo ^a   Iekushi, Kazuma ^a   Rakugi, Hiromi ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cavitation; Electroporation; Hydrodynamic method; Microbubble; Peripheral artery disease (PAD); Plasmid DNA; Ultrasound

Indexed keywords

BETA GALACTOSIDASE; DNA VACCINE; ECHO CONTRAST MEDIUM; FIBROBLAST GROWTH FACTOR; FLUOROCARBON; GLYCOPROTEIN GP 100; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 2; LIPOPLEX; LUCIFERASE; MACROGOL; PLACEBO; PLASMID DNA; POLYETHYLENEIMINE; RECOMBINANT VASCULOTROPIN; SCATTER FACTOR; SMALL INTERFERING RNA; THYMIDINE KINASE; TRANSCRIPTION FACTOR E2F; VASCULOTROPIN 165; VASCULOTROPIN A; VIRUS VECTOR;

AMPUTATION; ANGIOGENIC GENE THERAPY; ANTISENSE THERAPY; BLOOD CLOT LYSIS; CELL LINE; CRITICAL LIMB ISCHEMIA; CYSTIC FIBROSIS; DNA IMMUNIZATION; DNA TRANSFECTION; DRUG DOSE ESCALATION; DRUG MEGADOSE; ELECTRON MICROSCOPY; ELECTROPORATION; EXPRESSION VECTOR; FIBROBLAST; GENE EXPRESSION; GENE GUN; GENE TARGETING; GENE TRANSFER; HEART MUSCLE; HUMAN; HYDRODYNAMICS BASED TRANSFECTION; IMMUNOGENICITY; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; ISCHEMIC HEART DISEASE; ISOLATED LIVER; JET INJECTION; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CELL; MELANOMA; MELANOMA CELL; MICROBUBBLE; NEOPLASM; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE MEDIATED EPIDERMAL DELIVERY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POLYMERIZATION; REPORTER GENE; REVIEW; SKELETAL MUSCLE; TOXICITY; ULTRASOUND; VIRAL GENE THERAPY; WILD TYPE;

ANIMALS; BIOLISTICS; CLINICAL TRIALS AS TOPIC; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ELECTROPORATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; MICROBUBBLES; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL ARTERIAL DISEASE; PLASMIDS; SONICATION;

EID: 84867527530     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612803531342     Document Type: Review

References (83)

1. Check, E. Gene therapy: Shining hopes dented - but not dashed. Nature. 2002, 420, 735.
2. Marshall, E. Gene therapy death prompts review of adenovirus vector. Science. 1999, 286, 2244-2245.
3. Nikol, S. Baumgartner, I.; Van Belle, E.; Diehm, C.; Visona, A.; Capogrossi, M.C.; Ferreira-Maldent, N.; Gallino, A.; Wyatt, M.G.; Wijesinghe, L.D.; Fusari, M.; Stephan, D.; Emmerich, J.; Pompilio, G.; Vermassen, F.; Pham, E.; Grek, V.; Coleman, M.; Meyer, F. Therapeutic angiogenesis with intramuscular nv1fgf improves amputation-free survival in patients with critical limb ischemia. Mol. Ther., 2008, 16, 972-978.
4. Belch, J.; Hiatt, W.R.; Baumgartner, I.; Drver, IV.; Nikol, S.; Van Belle, E. TAMARIS Committes Investigator. Effect of fibroblast growth factor nv1fgf on amputation and death: A randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet. 2011, 377, 1929-1937.
5. Shigematsu, H.; Yasuda, K.; Iwai, T.; Sasajima, T.; Ishimaru, S.; Ohashi, Y.; Yamaguchi, T.; Ogihara, T.; Morishita, R. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther., 2010, 17, 1152-1161.
6. Kastrup, J.; Jorgensen, E.; Ruck, A.; Tagil, K.; Glogar, D.; Ruzyllo, W.; Botker, H.E.; Dudek, D.; Drvota, V.; Hesse, B.; Thuesen, L.; Blomberg, P.; Gyongyosi, M.; Sylven, C. Direct intramyocardial plasmid vascular endothelial growth factor-a165 gene therapy in patients with stable severe angina pectoris a randomized doubleblind placebo-controlled study: The euroinject one trial. J. Am. Coll. Cardiol., 2005, 45, 982-988.
7. Stewart, D.J.; Kutryk, M.J.; Fitchett, D.; Freeman, M.; Camack, N.; Su, Y.; Della Siega, A.; Bilodeau, L.; Burton, J.R.; Proulx, G.; Radhakrishnan, S. Vegf gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the northern trial. Mol. Ther., 2009, 17, 1109-1115.
8. Grines, C.L.; Watkins, M.W.; Helmer, G.; Penny, W.; Brinker, J.; Marmur, J.D.; West, A.; Rade, J.J.; Marrott, P.; Hammond, H.K.; Engler, R.L. Angiogenic gene therapy (agent) trial in patients with stable angina pectoris. Circulation. 2002, 105, 1291-1297.
9. Grines, C.L.; Watkins, M.W.; Mahmarian, J.J.; Iskandrian, A.E.; Rade, J.J.; Marrott, P.; Pratt, C.; Kleiman, N. A randomized, double-blind, placebo-controlled trial of ad5fgf-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J. Am. Coll. Cardiol., 2003, 42, 1339-1347.
10. Henry, T.D.; Grines, C.L.; Watkins, M.W.; Dib, N.; Barbeau, G.; Moreadith, R.; Andrasfay, T.; Engler, R.L. Effects of ad5fgf-4 in patients with angina: An analysis of pooled data from the agent-3 and agent-4 trials. J. Am. Coll. Cardiol., 2007, 50,1038-1046.
11. Dormandy, J.; Mahir, M.; Ascady, G.; Balsano, F.; De Leeuw, P.; Blombery, P.; Bousser, M.G.; Clement, D.; Coffman, J.; Deutshinoff, A. Fate of the patient with chronic leg ischaemia. A review article. J. Cardiovasc. Surg. (Torino)., 1989, 30, 50-57.
12. Rutherford, R. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the ad hoc committee on reporting standards, society for vascular surgery/north american chapter, international society for cardiovascular surgery. J. Vasc. Surg., 1986, 4, 80-94.
13. Rajagopalan, S.; Mohler, E.R. 3rd; Lederman, R.J.; Mendelsohn, F.O.; Saucedo, J.F.; Goldman, C.K.; Blebea, J.; Macko, J.; Kessler, P.D.; Rasmussen, H.S.; Annex, B.H.; Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase ii randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003, 108, 1933-1938.
14. P.M.; Mendelsohn, F.; Henry, T.D.; Hermiller, J.B.; Litt, M.; Saucedo, J.F.; Weiss, R.J.; Kandzari, D.E.; Kleiman, N.; Anderson, R.D.; Gottlieb, D.; Karlsberg, R.; Snell, J.; Rocha-Singh, K. Results from a phase ii multicenter, double-blind placebocontrolled study of del-1 (vlts-589) for intermittent claudication in subjects with peripheral arterial disease. Am. Heart. J., 2007, 153, 874-880.
15. Powell, R.J.; Simons, M.; Mendelsohn, F.O.; Daniel, G.; Henry, T.D.; Koga, M.; Morishita, R.; Annex, B.H. Results of a doubleblind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation. 2008, 118, 58-65.
16. Ueno, H.; Li, J.J.; Masuda, S.; Qi, Z.; Yamamoto, H.; Takeshita, A. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (fgf-2) induces cellular proliferation and angiogenesis in vivo. Arterioscler. Thromb. Vasc. Biol., 19971, 7, 2453-2460.
17. Takahashi, J.C.; Saiki, M.; Miyatake, S.; Tani, S.; Kubo, H.; Goto, K.; Aoki, T.; Takahashi, J.A.; Nagata, I.; Kikuchi, H. Adenovirusmediated gene transfer of basic fibroblast growth factor induces in vitro angiogenesis. Atherosclerosis. 1997, 132, 199-205.
18. Giordano, F.J.; Ping, P.; McKirnan, M.D.; Nozaki, S.; DeMaria, A.N.; Dillmann, W.H.; Mathieu-Costello, O.; Hammond, H.K. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat. Med., 1996, 2, 534-539.
19. Schwarzacher, S.P.; Uren, N.G.; Ward, M.R.; Schwarzkopf, A.; Giannetti, N.; Hunt, S.; Fitzgerald, P.J.; Oesterle, S.N.; Yeung, A.C. Determinants of coronary remodeling in transplant coronary disease: A simultaneous intravascular ultrasound and doppler flow study. Circulation. 2000, 101, 1384-1389.
20. Gowdak, L.H.; Poliakova, L.; Wang, X.; Kovesdi, I.; Fishbein, K.W.; Zacheo, A.; Palumbo, R.; Straino, S.; Emanueli, C.; Marrocco-Trischitta M, Lakatta EG, Anversa P, Spencer RG, Talan M, Capogrossi MC. Adenovirus-mediated vegf(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation. 2000, 102, 565-571.
21. Dzau, V.J.; Mann, M.J.; Morishita, R.; Kaneda, Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc. Natl. Acad. Sci. U S A. 1996, 93, 11421-11425.
22. Wolff, J.A.; Malone, R.W.; Williams, P.; Chong, W.; Acsadi, G.; Jani, A.; Felgner, P.L. Direct gene transfer into mouse muscle in vivo. Science. 1990, 247, 1465-1468.
23. Tachibana, K.; Tachibana, S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation. 1995, 92, 1148-1150.
24. Tachibana, K.; Uchida, T.; Ogawa, K.; Yamashita, N.; Tamura, K. Induction of cell-membrane porosity by ultrasound. Lancet. 1999, 353, 1409.
25. Taniyama, Y.; Tachibana, K.; Hiraoka, K.; Aoki, M.; Yamamoto, S.; Matsumoto, K.; Nakamura, T.; Ogihara, T.; Kaneda, Y.; Morishita, R. Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 2002, 9, 372-380.
26. Taniyama, Y.; Tachibana, K.; Hiraoka, K.; Namba, T.; Yamasaki, K.; Hashiya, N.; Aoki, M.; Ogihara, T.; Yasufumi, K.; Morishita, R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation. 2002, 105, 1233-1239.
27. Suzuki, J.; Ogawa, M.; Takayama, K.; Taniyama, Y.; Morishita, R.; Hirata, Y.; Nagai, R.; Isobe, M. Ultrasound-microbubblemediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. J. Am. Coll. Cardiol., 2010,55, 904-913.
28. Shimamura, M.; Sato, N.; Taniyama, Y.; Kurinami, H.; Tanaka, H.; Takami, T.; Ogihara, T.; Tohyama, M.; Kaneda, Y.; Morishita R. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. J. Gene Med., 2005, 7, 1468-1474.
29. Koike, H.; Tomita, N.; Azuma, H.; Taniyama, Y.; Yamasaki, K.; Kunugiza, Y.; Tachibana, K.; Ogihara, T.; Morishita, R. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J. Gene Med., 2005, 7, 108-116.
30. Shimamura, M.; Sato, N.; Taniyama, Y.; Yamamoto, S.; Endoh, M.; Kurinami, H.; Aoki, M.; Ogihara, T.; Kaneda, Y.; Morishita, R. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther., 2004, 11, 1532-1539.
31. Hashiya, N.; Aoki, M.; Tachibana, K.; Taniyama, Y.; Yamasaki, K.; Hiraoka, K.; Makino, H.; Yasufumi, K.; Ogihara, T.; Morishita, R. Local delivery of e2f decoy oligodeoxynucleotides using ultrasound with microbubble agent (optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem. Biophys. Res. Commun., 2004, 317, 508-514.
32. Al-Dosari, M.S.; Gao, X. Nonviral gene delivery: Principle, limitations, and recent progress. AAPS J., 2009, 11, 671-681.
33. Taniyama, Y.; Azuma, J.; Rakugi, H.; Morishita, R. Plasmid DNA- based gene transfer with ultrasound and microbubbles. Curr. Gene Ther., 2011, 11, 485-490.
34. Fechheimer, M.; Boylan, J.F.; Parker, S.; Sisken, J.E.; Patel, G.L.; Zimmer, S.G. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc. Natl. Acad. Sci. U S A. 1987, 84, 8463-8467.
35. Porter, T.R.; Iversen, P.L.; Li, S.; Xie, F. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbonexposed sonicated dextrose albumin microbubbles. J. Ultrasound Med., 1996, 15, 577-584.
36. Bao, S.; Thrall, B.D.; Miller, D.L. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol., 1997, 23, 953-959.
37. Feril, L.B. Jr.; Kondo, T.; Zhao, Q.L.; Ogawa, R.; Tachibana, K.; Kudo, N.; Fujimoto, S.; Nakamura, S. Enhancement of ultrasoundinduced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med. Biol., 2003, 29, 331-337.
38. Greenleaf, W.J.; Bolander, M.E.; Sarkar, G.; Goldring, M.B.; Greenleaf, J.F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med. Biol., 1998, 24, 587-595.
39. Suzuki, G. Recent progress in plant reproduction research: The story of the male gametophyte through to successful fertilization. Plant Cell Physiol., 2009, 50, 1857-1864.
40. Unger EC, Hersh E, Vannan M, Matsunaga TO, McCreery T. Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis., 2001, 44, 45-54.
41. Kudo, N.; Okada, K.; Yamamoto, K. Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys, J., 2009, 96, 4866-4876.
42. Tachibana, K.; Tachibana, S. Transdermal delivery of insulin by ultrasonic vibration. J. Pharm. Pharmacol., 1991, 43, 270-271.
43. Tachibana, K.; Tachibana, S. Use of ultrasound to enhance the local anesthetic effect of topically applied aqueous lidocaine. Anesthesiology. 1993, 78, 1091-1096.
44. Tachibana, K.; Tachibana, S. The use of ultrasound for drug delivery. Echocardiography. 2001, 18, 323-328.
45. Neumann, E.; Schaefer-Ridder, M.; Wang, Y.; Hofschneider, P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J., 1982, 1, 841-845.
46. Titomirov, A. V.; Sukharev, S.; Kistanova, E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim. Biophys. Acta. 1991, 1088, 131-134.
47. Heller, R.; Jaroszeski, M.; Atkin, A.; Moradpour, D.; Gilbert, R.; Wands, J.; Nicolau, C. In vivo gene electroinjection and expression in rat liver. FEBS Lett., 1996, 389, 225-228.
48. Suzuki, T.; Shin, B.C.; Fujikura, K.; Matsuzaki, T.; Takata, K. Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett., 1998, 425, 436-440.
49. Nishi, T.; Yoshizato, K.; Yamashiro, S.; Takeshima, H.; Sato, K.; Hamada, K.; Kitamura, I.; Yoshimura, T.; Saya, H.; Kuratsu, J.; Ushio, Y. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res., 1996, 56, 1050-1055.
50. Muramatsu, T.; Shibata, O.; Ryoki, S.; Ohmori, Y.; Okumura, J. Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem. Biophys. Res. Commun., 1997, 233, 45-49.
51. Oshima, Y.; Sakamoto, T.; Yamanaka, I.; Nishi, T.; Ishibashi, T.; Inomata, H. Targeted gene transfer to corneal endothelium in vivo by electric pulse. Gene Ther., 1998, 5, 1347-1354.
52. Aihara, H.; Miyazaki, J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol., 1998, 16, 867-870.
53. Rols, M.P.; Delteil, C.; Golzio, M.; Dumond, P.; Cros, S.; Teissie, J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat. Biotechnol., 1998, 16, 168-171.
54. Tsujie, M.; Isaka, Y.; Nakamura, H.; Imai, E.; Hori, M. Electroporation-mediated gene transfer that targets glomeruli. J. Am. Soc. Nephrol., 2001, 12, 949-954.
55. Matsumoto, T.; Komori, K.; Shoji, T.; Kuma, S.; Kume, M.; Yamaoka, T.; Mori, E.; Furuyama, T.; Yonemitsu, Y.; Sugimachi, K. Successful and optimized in vivo gene transfer to rabbit carotid artery mediated by electronic pulse. Gene. Ther., 2001, 8, 1174-1179.
56. Dean, D.A.; Machado-Aranda, D.; Blair-Parks, K.; Yeldandi, A.V.; Young, J.L. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther., 2003, 10, 1608-1615.
57. Escoffre, J.M.; Portet, T.; Wasungu, L.; Teissie, J.; Dean, D.; Rols, M.P. What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol. Biotechnol., 2009, 41, 286-295.
58. Zaharoff, D.A.; Henshaw, J.W.; Mossop, B.; Yuan, F. Mechanistic analysis of electroporation-induced cellular uptake of macromolecules. Exp. Biol. Med,. (Maywood). 2008, 233,94-105.
59. Faurie, C.; Rebersek, M.; Golzio, M.; Kanduser, M.; Escoffre, J.M.; Pavlin, M.; Teissie, J.; Miklavcic, D.; Rols, M.P. Electromediated gene transfer and expression are controlled by the lifetime of DNA/membrane complex formation. J. Gene Med., 2010, 12, 117-125.
60. L.; Mander, A.; McCann, K.; Dearnaley, D.; Tjelle, T.; Mathiesen, I.; Stevenson, F.; Ottensmeier, C.H. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum. Gene Ther., 2009, 20, 1269-1278.
61. Heller, L.C.; Heller, R. Electroporation gene therapy preclinical and clinical trials for melanoma. Curr. Gene Ther., 2010, 10, 312-317.
62. Daud, A.I.; DeConti, R.C.; Andrews, S.; Urbas, P.; Riker, A.I.; Sondak, V.K.; Munster P.N.; Sullivan, D.M.; Ugen, K.E.; Messina, J.L.; Heller, R. Phase i trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J. Clin. Oncol., 2008, 26, 5896-5903.
63. Klein, R.M.; Wolf, E.D.; Wu, R.; Sanford, J.C. High-velocity microprojectiles for delivering nucleic acids into living cells. 1987. Biotechnology. 1992, 24, 384-386.
64. Fuller, D.H.; Loudon, P.; Schmaljohn, C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods. 2006, 40, 86-97.
65. Drape, R.J.; Macklin, M.D.; Barr, L.J.; Jones, S.; Haynes, J.R.; Dean, H.J. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine. 2006, 24, 4475-4481.
66. Jones, S.; Evans, K.; McElwaine-Johnn, H.; Sharpe, M.; Oxford, J.; Lambkin-Williams, R.; Mant, T.; Nolan, A.; Zambon, M.; Ellis, J.; Beadle, J.; Loudon, P.T. DNA vaccination protects against an influenza challenge in a double-blind randomised placebocontrolled phase 1b clinical trial. Vaccine. 2009, 27, 2506-2512.
67. Cassaday, R.D.; Sondel, P.M.; King, D.M.; Macklin, M.D.; Gan, J.; Warner, T.F.; Zuleger, C.L.; Bridges, A.J.; Schalch, H.G.; Kim, K.M.; Hank, J.A.; Mahvi, D.M.; Albertini, M.R. A phase i study of immunization using particle-mediated epidermal delivery of genes for gp100 and gm-csf into uninvolved skin of melanoma patients. Clin. Cancer. Res., 2007, 13, 540-549.
68. Liu, F.; Song, Y.; Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther., 1999, 6, 1258-1266.
69. Eastman, S.J.; Baskin, K.M.; Hodges, B.L.; Chu, Q.; Gates, A.; Dreusicke, R.; Anderson, S.; Scheule, R.K. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum. Gene Ther., 2002, 13, 2065-2077.
70. Zhang, G.; Gao, X.; Song, Y.K.; Vollmer, R.; Stolz, D.B.; Gasiorowski, J.Z.; Dean, D.A.; Liu, D. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther., 2004, 11, 675-682.
71. Herweijer, H.; Wolff, J.A. Gene therapy progress and prospects: Hydrodynamic gene delivery. Gene Ther., 2007, 14, 99-107.
72. Ren, S.; Li, M.; Smith, J.M.; DeTolla, L.J.; Furth, P.A. Lowvolume jet injection for intradermal immunization in rabbits. BMC Biotechnol., 2002, 2, 10.
73. Cartier, R.; Ren, S.V.; Walther, W.; Stein, U.; Lewis, A.; Schlag, P.M.; Li, M.; Furth, P.A. In vivo gene transfer by low-volume jet injection. Anal. Biochem., 2000, 282, 262-265.
74. Kunugiza, Y.; Tomita, N.; Taniyama, Y.; Tomita, T.; Osako, M.K.; Tamai, K.; Tanabe, T.; Kaneda, Y.; Yoshikawa, H.; Morishita, R. Acceleration of wound healing by combined gene transfer of hepatocyte growth factor and prostacyclin synthase with shima jet. Gene Ther., 2006, 13, 1143-1152.
75. Walther, W.; Siegel, R.; Kobelt, D.; Knosel, T.; Dietel, M.; Bembenek, A.; Aumann, J.; Schleef M, Baier R, Stein U, Schlag PM. Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer. Clin. Cancer Res., 2008, 14, 7545-7553.
76. Felgner, P.L.; Gadek, T.R.; Holm, M.; Roman, R.; Chan, H.W.; Wenz, M.; Northrop, J.P.; Ringold, G.M.; Danielsen, M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U S A. 1987, 84, 7413-7417.
77. Xu, L.; Huang, C.C.; Huang, W.; Tang, W.H.; Rait, A.; Yin, Y.Z.; Cruz, I.; Xiang, L.M.; Pirollo, K.F.; Chang, E.H. Systemic tumortargeted gene delivery by anti-transferrin receptor scfvimmunoliposomes. Mol. Cancer Ther. 2002, 1, 337-346.
78. Durcan, N.; Murphy, C.; Cryan, S.A. Inhalable sirna: Potential as a therapeutic agent in the lungs. Mol. Pharm., 2008, 5, 559-566.
79. Farjo, R.; Skaggs J, Quiambao, A.B.; Cooper, M.J.; Naash, M.I. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One. 2006, 1,e38.
80. Boussif, O.; Lezoualc'h, F.; Zanta, M.A.; Mergny, M.D.; Scherman, D.; Demeneix, B.; Behr, J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U S A. 1995, 92, 7297-7301.
81. Wu, G.Y.; Wu, C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol., Chem. 1987, 262, 4429-4432.
82. Ziady, A.G.; Gedeon, C.R.; Miller, T.; Quan, W.; Payne, J.M.; Hyatt, S.L.; Fink, T.L.; Muhammad, O.; Oette, S.; Kowalczyk, T.; Pasumarthy, M.K.; Moen, R.C.; Cooper, M.J.; Davis, P.B. Transfection of airway epithelium by stable pegylated poly-l-lysine DNA nanoparticles in vivo. Mol. Ther., 2003, 8, 936-947.
83. Konstan, M.W.; Davis, P.B.; Wagener, J.S.; Hilliard, K.A.; Stern, R.C.; Milgram, L.J.; Kowalczyk, T.H.; Hyatt, S.L.; Fink, T.L.; Gedeon, C.R.; Oette, S.M.; Payne, J.M.; Muhammad, O.; Ziady, A.G.; Moen, R.C.; Cooper, M.J. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum. Gene Ther., 2004, 15, 1255-1269.